Prostate Cancer
Prostate Cancer
PrintE-mailPDF
The Prostate Pros – National Experts
At RPCI, teams of doctors work together to determine the best treatment plan for each patient. Board-certified physicians – specialists in surgery, radiation, medicine, pathology, radiology – collaborate to provide the best care.
RPCI is a member of the NCCN, an alliance of the nation’s top cancer centers, which develops the most widely used guidelines for cancer early detection and treatment. RPCI physicians who are members of the NCCN Guidelines Committee are:
- James Mohler, MD, Chair of Urology and Chair of the Prostate Cancer Treatment Guideline Committee
- Michael Kuettel, MD, PhD, MBA, Chair of Radiation Medicine and co-author of the original Prostate Cancer Treatment Guideline (1999)
What you need to know:
Men diagnosed with prostate cancer have several treatment options from which to choose. The treatment that is best for one man may not be best for another. At RPCI, men are encouraged to take an active role in making decisions about their care by learning about each treatment option and its expected benefits and side effects.
Prostate care at RPCI integrates surgical, radiation, and medical oncology specialists tailoring personalized treatment plans. They work in concert with your primary care physician, ensuring continuity of care from diagnosis through long-term follow-up. Strong connections between research and clinical care is evident in medical advances and technologies developed at RPCI:
- Robot-assisted surgery and other minimally invasive techniques are now used to perform 99% of prostate cancer surgeries at Roswell Park.
- Prostate Specific Antigen (PSA) test detects prostate cancer 5–10 years earlier than previous screening methods.
- LNCaP, the most studied prostate cancer cell line in the world.
Don’t Panic. Decisions Take Time.
Michael R. Kuettel, MD, PhD, MBA, says, "prostate patients should thoroughly weigh their treatment options before deciding what to do".
